KR900700626A - 사람 면역결핍 바이러스-1 gp160으로부터 유도된 보호 펩티드 - Google Patents

사람 면역결핍 바이러스-1 gp160으로부터 유도된 보호 펩티드

Info

Publication number
KR900700626A
KR900700626A KR1019890702406A KR890702406A KR900700626A KR 900700626 A KR900700626 A KR 900700626A KR 1019890702406 A KR1019890702406 A KR 1019890702406A KR 890702406 A KR890702406 A KR 890702406A KR 900700626 A KR900700626 A KR 900700626A
Authority
KR
South Korea
Prior art keywords
immunodeficiency virus
human immunodeficiency
peptide derived
protective peptide
protective
Prior art date
Application number
KR1019890702406A
Other languages
English (en)
Korean (ko)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR900700626A publication Critical patent/KR900700626A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1019890702406A 1988-04-20 1989-12-20 사람 면역결핍 바이러스-1 gp160으로부터 유도된 보호 펩티드 KR900700626A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18384088A 1988-04-20 1988-04-20
PCT/US1989/001621 WO1989010416A1 (fr) 1988-04-20 1989-04-18 PEPTIDES PROTECTEURS DERIVES DU VIRUS-1 gp160 D'IMMUNODEFICIENCE HUMAIN

Publications (1)

Publication Number Publication Date
KR900700626A true KR900700626A (ko) 1990-08-16

Family

ID=22674513

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890702406A KR900700626A (ko) 1988-04-20 1989-12-20 사람 면역결핍 바이러스-1 gp160으로부터 유도된 보호 펩티드

Country Status (7)

Country Link
KR (1) KR900700626A (fr)
AU (1) AU3557889A (fr)
CA (1) CA1341391C (fr)
IE (1) IE61966B1 (fr)
PT (1) PT90329B (fr)
WO (1) WO1989010416A1 (fr)
ZA (1) ZA892907B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
US5840313A (en) * 1990-09-27 1998-11-24 Syntello Vaccine Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
WO1992005800A1 (fr) * 1990-09-27 1992-04-16 Syntello Vaccin Development Kb Peptides destines a etre utilises dans la vaccination et dans l'induction d'anticorps neutralisants pour lutter contre le virus d'immunodeficience humaine
WO1992021377A1 (fr) * 1991-06-03 1992-12-10 Syntello Inc. Peptides a utiliser pour induire l'activation de lymphocytes t contre le vih-1
FR2677364A1 (fr) * 1991-06-05 1992-12-11 Pasteur Institut Sequences peptidiques de la glycoproteine externe d'enveloppe du retrovirus hiv-1.
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
GB2313376A (en) * 1996-05-22 1997-11-26 Diapharm Limited Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide (VIP)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743678A (en) * 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus

Also Published As

Publication number Publication date
WO1989010416A1 (fr) 1989-11-02
CA1341391C (fr) 2002-10-01
PT90329B (pt) 1994-09-30
IE61966B1 (en) 1994-11-30
AU3557889A (en) 1989-11-24
PT90329A (pt) 1989-11-10
IE891260L (en) 1989-10-20
ZA892907B (en) 1990-03-28

Similar Documents

Publication Publication Date Title
ATA257190A (de) Virales polypeptid
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
NZ220653A (en) Hiv env region peptides and d-retro versions thereof
DK532787A (da) Peptidderivater
LTIP335A (en) Vaccine for human immunodeficiency virus
DE3777756D1 (de) Schutz fuer den ausgangsschalter eines schrittmachers.
DE69327153T2 (de) Anti-hiv-medikament
DK197989A (da) Peptidanaloger
KR900700626A (ko) 사람 면역결핍 바이러스-1 gp160으로부터 유도된 보호 펩티드
DK531986D0 (da) Peptider
DK354487A (da) Oncogen-relaterede peptider
DE69024400D1 (de) Dem menschlichen Calpastatin ähnliches Polypeptid
DK84489A (da) Praeparater
KR950700933A (ko) 사람 면역결핍 바이러스(HIV) 표면 당단백질로부터 유래된 합성 폴리펩타이드(Synthetic polypeptides derived from the HIV envelope glycoprotein)
KR900700503A (ko) 펩티드
KR900016262A (ko) 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드
KR900700509A (ko) 인간 거대세포 바이러스의 면역원성 당단백질
ZA883878B (en) Human immunodeficiency virus gag-encoded proteins
NO891691D0 (no) Rekombinant gag-forloeper for hiv.
ZA935165B (en) Developments relating to human immunodeficiency viruses
MC1830A1 (fr) Peptides
IE881635L (en) Human immunodeficiency virus gag-encoded proteins
GB2273710B (en) Peptide fragments of HIV
DE3990262T1 (de) Rekombinante retroviren
GB9111574D0 (en) Developments relating to human immunodeficiency viruses

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application